Skip to main content
OpenTrials

Clinical trial condition

Rhinitis, Allergic, Perennial

Explore clinical trials studying Rhinitis, Allergic, Perennial. Study availability and eligibility vary by location and protocol.

163 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Rhinitis, Allergic, Perennial trial results

Completed

To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)

NCT00659750

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • Altana/Nycomed Encinitas, California, United States
  • Altana/Nycomed Long Beach, California, United States
  • Altana/Nycomed Los Angeles, California, United States
  • Altana/Nycomed Mission Viejo, California, United States
View all 23 locations
View Trial Details
Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

NCT00163514

Conditions
Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations
  • Altana Pharma/Nycomed Oxford, Alabama, United States
  • Altana Pharma/Nycomed Huntington Beach, California, United States
  • Altana Pharma/Nycomed Mission Viejo, California, United States
  • Altana Pharma/Nycomed Newport Beach, California, United States
View all 74 locations
View Trial Details
Completed

Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404)

NCT00163501

Conditions
Allergic Rhinitis, Hay Fever, Hypersensitivity, +11 more
Locations
  • Altana Pharma/Nycomed Encinitas, California, United States
  • Altana Pharma/Nycomed Huntington Beach, California, United States
  • Altana Pharma/Nycomed Long Beach, California, United States
  • Altana Pharma/Nycomed Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

NCT00806754

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • Altana/Nycomed Encinitas, California, United States
  • Altana/Nycomed Los Angeles, California, United States
  • Altana/Nycomed Mission Viejo, California, United States
  • Altana/Nycomed San Diego, California, United States
View all 35 locations
View Trial Details
Completed

Long Term Safety Of GW685698X Via Nasal Biopsy

NCT00224523

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Leuven, Belgium
  • GSK Investigational Site Amsterdam, Netherlands
  • GSK Investigational Site Nijmegen, Netherlands
  • GSK Investigational Site The Hague, Netherlands
View Trial Details
Completed

A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).

NCT00103454

Conditions
Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +7 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Mission Viejo, California, United States
  • GSK Investigational Site Orange, California, United States
View all 49 locations
View Trial Details

Related conditions